Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alok V Joglekar

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Human Gene Therapy Methods|September 6, 2017
Pseudotyped Lentiviral Vectors: One Vector, Many GuisesAlok V Joglekar, Salemiz Sandoval
Nature Methods|July 8, 2020
T cell antigen discoveryAlok V Joglekar, Guideng Li
Current Opinion in Biotechnology|May 12, 2017
Personalized T cell-mediated cancer immunotherapy: progress and challengesMichael T Bethune, Alok V Joglekar
Nature Methods|December 8, 2025
TIRTL-seq: heroes with T-SHELLMary Melissa Roland, Alok V Joglekar
NPJ Systems Biology and Applications|January 20, 2025
Immunopeptidomics for autoimmunity: unlocking the chamber of immune secretsSanya Arshad, Benjamin Cameron, Alok V Joglekar
Cancer Immunology Research|April 1, 2024
Living in Syn: T Cell Antigen Identification Based on Synapse SequencingVenkata Krishna Kanth Makani, Alok V Joglekar
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2025
T Cell Antigen Discovery Using Cell-Based Epitope LibrariesPaul M Zdinak, Sanya Arshad, Venkata Krishna Kanth Makani, et al.
Molecular Metabolism|September 21, 2023
The beta cell-immune cell interface in type 1 diabetes (T1D)Eddie A James, Alok V Joglekar, Amelia K Linnemann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locusAlok V Joglekar, Roger P Hollis, Gabriela Kuftinec, et al.
Human Gene Therapy|February 27, 2014
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectorsAlok V Joglekar, Libby Stein, Michelle Ho, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Human Gene Therapy Methods|September 6, 2017
Pseudotyped Lentiviral Vectors: One Vector, Many GuisesAlok V Joglekar, Salemiz Sandoval
Nature Methods|July 8, 2020
T cell antigen discoveryAlok V Joglekar, Guideng Li
Current Opinion in Biotechnology|May 12, 2017
Personalized T cell-mediated cancer immunotherapy: progress and challengesMichael T Bethune, Alok V Joglekar
Nature Methods|December 8, 2025
TIRTL-seq: heroes with T-SHELLMary Melissa Roland, Alok V Joglekar
NPJ Systems Biology and Applications|January 20, 2025
Immunopeptidomics for autoimmunity: unlocking the chamber of immune secretsSanya Arshad, Benjamin Cameron, Alok V Joglekar
Cancer Immunology Research|April 1, 2024
Living in Syn: T Cell Antigen Identification Based on Synapse SequencingVenkata Krishna Kanth Makani, Alok V Joglekar
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2025
T Cell Antigen Discovery Using Cell-Based Epitope LibrariesPaul M Zdinak, Sanya Arshad, Venkata Krishna Kanth Makani, et al.
Molecular Metabolism|September 21, 2023
The beta cell-immune cell interface in type 1 diabetes (T1D)Eddie A James, Alok V Joglekar, Amelia K Linnemann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locusAlok V Joglekar, Roger P Hollis, Gabriela Kuftinec, et al.
Human Gene Therapy|February 27, 2014
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectorsAlok V Joglekar, Libby Stein, Michelle Ho, et al.
Pageof 3